Peritoneal carcinomatosis from colorectal cancer

No abstract is available for this paper.

• Publication year

  2002

• Venue

  British Journal of Surgery

• Publication date

  2002-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/J.1365-2168.2002.02274.XPMID 12445064
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin.

  2001cited by this paper
• Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy

  2001cited by this paper
• Complications et tolérance de la chimio-hyperthermie intrapéritonéale (CHIP) après exérèse chirurgicale des carcinoses péritonéales (CP) : résultats d'une étude de phase I-II portant sur des CP de différentes origines

  2000cited by this paper
• Treatment of primary colon cancer with peritoneal carcinomatosis

  2000cited by this paper
• Peritoneal carcinomatosis from non‐gynecologic malignancies

  2000cited by this paper
• [Complications and tolerance of heated intraperitoneal chemotherapy and cytoreductive surgery for peritoneal carcinomatosis: results of a phase I-II study of peritoneal carcinomatosis from different sources].

  2000cited by this paper
• Thoracic complications in patients undergoing intraperitoneal heated chemotherapy with mitomycin following cytoreductive surgery

  1997cited by this paper
• Peritoneal carcinomatosis from adenocarcinoma of the colon.

  1996cited by this paper
• Colorectal cancer and peritoneal carcinomatosis.

  1996cited by this paper
• Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy

  1996cited by this paper
• Prognostic Features of 51 Colorectal and 130 Appendiceal Cancer Patients with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy

  1995cited by this paper
• Patient selection and treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer

  1995cited by this paper
• Peritonectomy procedures.

  1995cited by this paper
• Recurrent pattern of digestive tract carcinoma in the Japanese: comparison of gastric cancer to colon cancer.

  1995cited by this paper
• Morbidity and mortality of cytoreductive surgery and intraperitoneal chemotherapy.

  1993cited by this paper
• Intraoperative spillage of tumor cells in surgery for rectal cancer

  1990cited by this paper
• Peritioneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors

  1989cited by this paper
• Bowel obstruction in cancer patients: Performance status as a predictor of survival

  1984cited by this paper
• The effect of inadvertent intraoperative perforation on survival and recurrence in colorectal cancer

  1984cited by this paper
• Prognostic significance of surgical perforation of the rectum during abdominoperineal resection for rectal carcinoma.

  1982cited by this paper
• Effect of surgical removal on the growth and kinetics of residual tumor.

  1979cited by this paper

• Experiences and Hopes Among Patients with Colorectal Carcinoma and Peritoneal Metastases Who Are Participating in an Early-Phase Clinical Trial

  2026cites this paper
• The epidemiology, current evidence and controversies in diagnosis and management of patients with colorectal peritoneal metastases.

  2025cites this paper
• Epidemiology of carcinomatosis.

  2025cites this paper
• Intraperitoneal Infusion of NKG2D CAR-NK cells Induces Endogenous CD8+ T Cell Activation in Patients with Advanced Colorectal Cancer.

  2025cites this paper
• Prophylactic Intraperitoneal Chemotherapy with Platinum Agents Following Curative Resection for Colorectal Cancer: A Systematic Review and Meta-Analysis.

  2025cites this paper
• An ABCC1-based risk model is effective in the diagnosis of synchronous peritoneal metastasis in advanced colorectal cancer

  2025cites this paper
• Shaping the microenvironment in peritoneal metastases

  2025cites this paper
• Prognostic Analysis of Prophylactic Hyperthermic Intraperitoneal Chemotherapy for Advanced Colorectal Cancer: A Propensity Score Matching Analysis

  2025cites this paper
• ASO Practice Guideline Series: Management of Colorectal Peritoneal Metastases

  2025cites this paper
• Discovery of circulating cell-free DNA 5hmC biomarkers for peritoneal metastasis in colorectal and appendiceal cancer

  2025cites this paper
• Clinical significance of preoperative Glasgow prognostic score in patients with colorectal cancer and synchronous peritoneal metastases

  2025cites this paper
• Palliative cytoreductive surgery with hyperthermic chemotherapy for peritoneal carcinomatosis

  2025cites this paper
• The Effect of Induced Hypothermia on Postoperative Outcomes Following Hyperthermic Intraperitoneal Chemotherapy: A Negative Finding

  2025cites this paper
• The use of ROTEM in Detection of Coagulopathy and Altered Hemostasis in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

  2025cites this paper
• Intraoperatively preventive intraperitoneal perfusion chemotherapy with lobaplatin in colorectal cancer: a prospective, randomised, controlled, multicentre study

  2025cites this paper
• Great Debate: Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases—Should It Be Offered?

  2025cites this paper
• Leveraging WNT Hyperactivation to Kill Colorectal Cancer While Rejuvenating Healthy Intestine

  2025cites this paper
• Multimodal management of peritoneal sarcomatosis in uterine sarcoma: Long term outcomes from a single institute in India.

  2025cites this paper
• Prophylactic hyperthermic intraperitoneal chemotherapy in locally advanced colorectal cancer: A propensity score matched cohort study.

  2025cites this paper
• The Significance of CEA and CA 19-9 Levels in Serum and Peritoneal Fluid in Colorectal Cancer Patients in the Context of Peritoneal Metastases and Cytology Results

  2025cites this paper
• Contemporary management of advanced colorectal cancer: the Australian experience

  2024cites this paper
• Clinical Outcomes and Prognostic Factors for R0 Resected Colorectal Cancer with Synchronous Peritoneal Metastasis: A Retrospective Study

  2024cites this paper
• Genetic specificity study using next-generation sequencing (NGS) of peritoneal metastatic colorectal cancer compared to primary colorectal cancer

  2024cites this paper
• The Importance of Preoperative NLR, PLR, and MPV Values in Predicting the Risk of Complications in Colorectal Peritoneal Carcinomatosis

  2024cites this paper
• Exploiting a subtype-specific mitochondrial vulnerability for successful treatment of colorectal peritoneal metastases

  2024cites this paper
• Follow-up for More than 10 Years of Patients with Peritoneal Metastases Treated with Cytoreductive Surgery + Hyperthermic Intraperitoneal Chemotherapy in a Specialized Unit

  2024cites this paper
• Survival Analysis and Recurrence Patterns in 555 Patients with Colorectal Peritoneal Metastases Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

  2024cites this paper
• Third-Line Treatment and Beyond in Metastatic Colorectal Cancer: What Do We Have and What Can We Expect?

  2024cites this paper
• Impact of obesity after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for rare peritoneal malignancies: Paradox of obesity or poor prognostic factor?

  2024cites this paper
• The safety and effectiveness of prophylactic hyperthermic intraperitoneal chemotherapy in patients with pathological T3-4 locally advanced colon cancer.

  2024cites this paper
• Metastatic Colorectal Cancer Treated with Combined Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Predictive Factors for Early Recurrence

  2024cites this paper
• Imaging in the era of risk-adapted treatment in Colon cancer.

  2024cites this paper
• Prophylactic hyperthermic intraperitoneal chemotherapy in T4 colorectal cancer: Can it improve the oncologic prognosis? - A propensity score matching study.

  2024cites this paper
• Normal CEA Levels After Neoadjuvant Chemotherapy and Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion Predict Improved Survival from Colorectal Peritoneal Metastases

  2024cites this paper
• Ascitis en el paciente no cirrótico

  2024cites this paper
• Updates in BRAF V600E-Mutated Metastatic Colorectal Cancer

  2024cites this paper
• Medicaid Expansion and Overall Survival of Lower Gastrointestinal Cancer Patients After Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy

  2024cites this paper
• Enhancing precision in colorectal cancer surgery: development of an LGR5-targeting RSPO1 peptide mimetic as a contrast agent for intraoperative fluorescence molecular imaging

  2024cites this paper
• Top Peritoneal Surface Malignancy Articles from 2022 to Inform your Cancer Practice

  2024influential citation
• Clinical Practice and Prognosis of Stage IV Colorectal Cancer

  2024cites this paper
• Education and Training in Peritoneal Surface Oncology

  2024cites this paper
• Neoadjuvant chemotherapy does not improve survival for patients with high volume colorectal peritoneal metastases undergoing cytoreductive surgery

  2024cites this paper
• Bidirectional Chemotherapy in Advanced Colorectal Cancer Peritoneal Metastases

  2023cites this paper
• CACA guidelines for holistic integrative management of rectal cancer

  2023cites this paper
• Immunological effects of heated intraperitoneal chemotherapy can be augmented by thymosin α1.

  2023cites this paper
• The molecular biology of peritoneal metastatic disease

  2023cites this paper
• Influence of Extraperitoneal Metastases on the Curative-Intent Management of Colorectal Peritoneal Metastases

  2023cites this paper
• Comparative Study of Short-Term Efficacy and Safety of Radical Surgery with or without Hyperthermic Intraperitoneal Chemotherapy in Colorectal Cancer with T4 Stage: A Propensity Score Matching Analysis

  2023cites this paper
• Predictive Genetic Biomarkers for the Development of Peritoneal Metastases in Colorectal Cancer

  2023cites this paper
• PI3K Pathway Alterations in Peritoneal Metastases are Associated with Earlier Recurrence in Patients with Colorectal Cancer Undergoing Optimal Cytoreductive Surgery

  2023cites this paper
• Epidemiology of Stage IV Colorectal Cancer: Trends in the Incidence, Prevalence, Age Distribution, and Impact on Life Span

  2023cites this paper
• DNA and RNA Alterations Associated with Colorectal Peritoneal Metastases: A Systematic Review

  2023cites this paper
• Consensus statement and clinical pathway for the management of colon cancer with peritoneal metastases in the state of Delaware.

  2023cites this paper
• Functional biomaterials for the diagnosis and treatment of peritoneal surface malignancies

  2023cites this paper
• Predictive factors of non-completion of cytoreductive surgery in colorectal peritoneal metastasis.

  2023cites this paper
• Intraperitoneal administration of carcinoembryonic antigen-directed chimeric antigen receptor T cells is a robust delivery route for effective treatment of peritoneal carcinomatosis from colorectal cancer in pre-clinical study.

  2023cites this paper
• Re-do cytoreductive surgery with hyperthermic intra-peritoneal chemotherapy (HIPEC): Risk factors and complications

  2023cites this paper
• Effect of BRAF mutation on the prognosis for patients with colorectal cancer undergoing cytoreductive surgery for synchronous peritoneal metastasis

  2023cites this paper
• Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still beneficial in patients diagnosed with colorectal peritoneal metastasis who underwent palliative chemotherapy?

  2023cites this paper
• Primary Colorectal Tumor Displays Differential Genomic Expression Profiles Associated with Hepatic and Peritoneal Metastases

  2023cites this paper
• Outcomes after curatively intended treatment of limited peritoneal metastases and thermal ablation for liver metastases from colorectal cancer

  2023cites this paper
• Citorreducción y quimioterapia hipertérmica transoperatoria en el manejo de la carcinomatosis por cáncer colorrectal: visión global de actualidad

  2023cites this paper
• Evolving role of cytoreduction and HIPEC for colorectal cancer

  2023cites this paper
• Treatment and prognosis of colorectal cancer with synchronous peritoneal metastases: 11-year single institute experience

  2023cites this paper
• Recommendations for the optimal management of peritoneal metastases in patients with colorectal cancer: a TTD and GECOP-SEOQ expert consensus statement

  2023cites this paper
• Cytoreductive Surgery and Hyperthermic Peritoneal Chemotherapy in Appendiceal and Colorectal Cancer: Outcomes and Survival

  2023cites this paper
• Assessing morbidity, mortality, and survival in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

  2023cites this paper
• Current Research and Development in Hyperthermic Intraperitoneal Chemotherapy (HIPEC)—A Cross-Sectional Analysis of Clinical Trials Registered on ClinicalTrials.gov

  2023cites this paper
• Impact of Molecular Status on Cytoreductive Surgery for Peritoneal Metastases from Colorectal Cancer

  2023cites this paper
• Outcomes of preoperative chemotherapy for colorectal cancer with peritoneal metastasis underwent cytoreductive surgery

  2023cites this paper
• Effect of adjuvant chemotherapy after curative resection of colorectal cancer peritoneal metastasis

  2023cites this paper
• Drug delivery systems for colorectal cancer chemotherapy

  2023cites this paper
• Recombinant Oral Methioninase (o-rMETase) Combined With Oxaliplatinum Plus 5-Fluorouracil Improves Survival of Mice With Massive Colon-Cancer Peritoneal Carcinomatosis

  2022cites this paper
• The Landmark Series: Scoring Systems for Primary Peritoneal Surface Malignancy

  2022cites this paper
• Peritoneal recurrence after resection for Stage I–III colorectal cancer: A population analysis

  2022cites this paper
• Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: Where do we stand?

  2022cites this paper
• Utilizing Patient-Derived Organoids in the Management of Colorectal Cancer with Peritoneal Metastases: A Review of Current Literature

  2022cites this paper
• Decellularized extracellular matrix as scaffold for cancer organoid cultures of colorectal peritoneal metastases

  2022cites this paper
• Prognostic Value of Preoperative Serological Biomarkers in Patients Undergoing Curative-Intent Cytoreductive Surgery for Colorectal Cancer Peritoneal Metastases

  2022cites this paper
• Recent Update on the Treatment of Colorectal Peritoneal Metastasis: A Surgical Perspective

  2022cites this paper
• Hyperthermic intraperitoneal chemotherapy for management of gastrointestinal and biliary tract malignancies: a systematic review and meta-analysis of randomized trials

  2022cites this paper
• Immune checkpoint inhibitors for patients with isolated peritoneal carcinomatosis from dMMR/MSI-H colorectal cancer, a BIG-RENAPE collaboration.

  2022cites this paper
• Long-term survivor who underwent surgical resections of repeated peritoneal oligometastases from colon cancer : a rare case report.

  2022cites this paper
• Advances in the management of peritoneal malignancies

  2022cites this paper
• External validation of COMPASS and BIOSCOPE prognostic scores in colorectal peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).

  2022cites this paper
• Long-term outcomes of elderly patients with peritoneal metastases of colorectal origin after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

  2022cites this paper
• Selection Factors for Treatment and Stratification of Rare Abdominal or Pelvic Tumors with Peritoneal Metastases

  2022cites this paper
• Molecular characterization of colorectal cancer related peritoneal metastatic disease

  2022influential citation
• Prediction of Metachronous Peritoneal Metastases After Radical Surgery for Colon Cancer: A Scoring System Obtained from an International Multicenter Cohort

  2022cites this paper
• Risk factors for metachronous peritoneal carcinomatosis after radical resection for patients with nonmetastatic pT3‐4 colon cancer

  2022cites this paper
• Comparison of survival outcomes using cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colon versus rectal cancer with peritoneal carcinomatosis in an asian medical center

  2022cites this paper
• Intraperitoneal drug delivery systems releasing cytostatic agents to target gastro-intestinal peritoneal metastases in laboratory animals: a systematic review

  2022cites this paper
• Oncological Outcomes After Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in the Treatment of Peritoneal Carcinomatosis

  2022cites this paper
• Young Man With Non-hypertensive Ascites of Unexpected Cause: When Ockham’s Razor Is Not Sufficient

  2022cites this paper
• Thymosin alpha 1 as an adjuvant to hyperthermic intraperitoneal chemotherapy in an experimental model of peritoneal metastases from colonic carcinoma.

  2022cites this paper
• Pelvic Peritonectomy Poorly Affects Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Metastases

  2022cites this paper
• Update for Advance CAR-T Therapy in Solid Tumors, Clinical Application in Peritoneal Carcinomatosis From Colorectal Cancer and Future Prospects

  2022cites this paper
• Occurrence of peritoneal carcinomatosis in patients with rectal cancer undergoing staging pelvic MRI: clinical observations

  2022cites this paper
• Is CRS-HIPEC Still Indicated in Patients With Extraperitoneal Disease?

  2022cites this paper
• Management of Peritoneal Disease in Colorectal Cancer.

  2022cites this paper